Market Pulse Archives

Aug. 27, 2021, 8:58 a.m. EDT

Cassava's stock tumbles again, after Quanterix said it 'did not' prepare data charts presented by Cassava, that are under dispute

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Quanterix Corp. (QTRX)
  • X
    Cassava Sciences Inc. (SAVA)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Quanterix Corp. /zigman2/quotes/208703756/composite QTRX -3.58% said that while it was previously engaged by Cassava Sciences Inc. /zigman2/quotes/204212356/composite SAVA -8.79% to perform sample testing, the digitized biomarker analysis company said it, or its employees, "did not interpret the test results or prepare the data charts" presented by Cassava to the Alzheimer's Association International Conference (AAIC) in July, or otherwise. Earlier this week, in Cassava's response to a request the Food and Drug Administration halt clinical studies of Cassava's Alzheimer's treatment because of concerns over the accuracy and integrity of presented biomarker data , Cassava had said that data from Alzheimer's patients were generated by Quanterix. The news of the halt request had sent Cassava's stock plunging 39.9% in two days through Thursday. Quanterix's stock dropped 9.2% on Thursday, after losing 1.5% on Wednesday. In Friday's statement, Quanterix said it is "widely recognized for its commitment to business integrity and to upholding the highest standards of quality." Quanterix's stock rose 4.5% in premarket trading, while Cassava shares tumbled 21.2%

/zigman2/quotes/208703756/composite
US : U.S.: Nasdaq
$ 38.54
-1.43 -3.58%
Volume: 391,924
Dec. 1, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.46 billion
Rev. per Employee
$275,086
loading...
/zigman2/quotes/204212356/composite
US : U.S.: Nasdaq
$ 48.79
-4.70 -8.79%
Volume: 2.47M
Dec. 1, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.14 billion
Rev. per Employee
N/A
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.